Henrique Bittencourt
St. Justine's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Henrique Bittencourt as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:37 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04731298 · Study to Investigate the Pharmacokinetics, Pharmacodynamics and Assess the Efficacy and Safety to Support Dose Selection of Emapalumab in Pre-empting Graft Failure in Patients at High Risk After HSCT.Swedish Orphan Biovitrum · terminated · Graft Failure · principal investigator
- Ph1/Ph2NCT02499861 · Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory MalignanciesSt. Justine's Hospital · completed · Cancer · principal investigator
- Ph2NCT01711788 · Intrabone Infusion of Umbilical Cord Blood Stem CellsHenrique Bittencourt, MD, PhD · completed · Hematopoietic Stem Cell Transplantation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:37 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.N Engl J Med · 20184,679 citationsRCR 163.2
- Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.J Clin Oncol · 2023345 citationsRCR 28.7
- Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.N Engl J Med · 2024139 citationsRCR 18.4
- 84 citationsRCR 3.0
- Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001.Blood Adv · 202277 citationsRCR 5.5
- Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.Blood · 202063 citationsRCR 3.2
- 49 citationsRCR 1.6
- Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients.Bone Marrow Transplant · 201344 citationsRCR 1.9
- Influence of glutathione S-transferase gene polymorphisms on busulfan pharmacokinetics and outcome of hematopoietic stem-cell transplantation in thalassemia pediatric patients.Bone Marrow Transplant · 201632 citationsRCR 1.7
- Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a canadian blood and marrow transplant group trial.Biol Blood Marrow Transplant · 201331 citationsRCR 1.2